Medison Ventures’ edge lies in access to over twenty years of clinical and commercial know-how accumulated by Medison Pharma , our parent company. We build proprietary deal-flow generating platforms, that are designed to identify and execute on opportunities that hold the potential to inject value to Medison and its partners.
ABOUT MEDISON
Medison Ventures is the corporate venture arm of Medison Pharma.
Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets.
Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments accessible to patients in international markets.
Medison has a track record of multi-territorial partnerships with leading pharmaceutical and biotech companies seeking to expand their global reach.
TRANSFORMATIVE HEALTHCARE
INNOVATION IS OUR NORTH STAR
Our holistic exposure to stakeholders across the spectrum is made possible through both eye-level relationships and an unprecedented access to Medison’s network. We fully immerse ourselves in the world of healthcare. We walk the hallways of academia and medical centers, listen to patients, engage with our global pharma partners, and meet with key opinion leaders.
With a rounded, patient-centric, industry-informed perspective, we search for and evaluate breakthrough technologies across various stages of development, prior to constructing an independent notion of both the problems being solved and the proposed solutions. Having assessed the industry’s willingness to adopt specific innovative solutions, we leverage strategic alliances and our investment vehicles to inject value into these innovative projects.
We seek highly innovative products at advanced stages of development to in-license and commercialize in the territories covered by Medison.
We view ourselves as ‘external R&D’ for Medison’s global partners. Each year, hundreds of projects are funneled into Medison Ventures via our team and global network. Our continuous research and evaluation is informed by a deep understanding and appreciation of each partners’ specific needs, allowing us to find tailored opportunities to further drive their pipeline needs and long-term vision.
Leveraging over two decades of clinical and commercial expertise from its parent company, Medison Ventures identifies and executes opportunities that add value to both Medison and its partners. The firm immerses itself in the healthcare ecosystem by engaging with academia, medical centers, patients, global pharma partners, and key opinion leaders. This comprehensive approach enables Medison Ventures to evaluate breakthrough technologies across various development stages and assess industry adoption readiness.
Medison Ventures has made notable investments in companies such as Alpha Tau Medical, Orchard Therapeutics, and Allogene Therapeutics, focusing on sectors like biotechnology and drug discovery.
Through its strategic alliances and investment vehicles, Medison Ventures seeks highly innovative products at advanced development stages for in-licensing and commercialization within Medison's covered territories. By acting as 'external R&D' for its global partners, the firm continuously researches and evaluates opportunities tailored to meet specific partner needs, driving pipeline growth and supporting long-term visions.
Our Approach
We operate as a bridge between innovation and impact, leveraging our expertise and global reach to bring transformative therapies to markets worldwide. By acting as an external R&D arm for our partners, we ensure that the most promising innovations reach patients who need them most.
Our Mission
Our mission is to identify, invest in, and support breakthrough biotech and digital health innovations that have the potential to revolutionize patient care and redefine therapeutic boundaries.
Strategic Investments:
We partner with visionary entrepreneurs and scientists, investing in early-to-late-stage life sciences and digital health companies.
Global Commercial Expertise:
Backed by Medison Pharma's decades of experience, we bring unparalleled market knowledge to guide innovations from lab to market.
Collaborative Ecosystem:
We engage with a diverse network of academic institutions, healthcare providers, and industry leaders to evaluate and nurture transformative healthcare solutions.